330
Participants
Start Date
August 3, 2020
Primary Completion Date
October 31, 2024
Study Completion Date
June 30, 2025
NanoBone Bone Graft Substitute
Synthetic, biodegradable bone grafting material that is composed of non-sintered nanocrystalline hydroxyapatite (HA) which is embedded in a silica gel matrix (amorphous SiO2). The ratio of HA/SiO2 has been chosen to optimize the rate of biodegradation for treatment of osseous defects in human bone. NanoBone does not contain any components of animal or human origin, eliminating the possibility of transmission of infection or disease.
OrthoBethesda, Bethesda
Sam Shamsnia MD Neurosurgery, Biloxi
OrthoArizona, Chandler
Sonoran Spine, Tempe
SENTA Clinic, San Diego
Hartford Health Care, Hartford
Lead Sponsor
Artoss Inc.
INDUSTRY